Association between ERCC1 and TS mRNA levels and disease free survival in colorectal cancer patients receiving oxaliplatin and fluorouracil (5-FU) adjuvant chemotherapy

被引：0
|
作者：
Sheng Li
Liangjun Zhu
Li Yao
Lei Xia
Liangxi Pan
机构：
[1] Jiangsu Tumor Hospital,Oncology
[2] First Hospital Affiliated to Suzhou University,Department of Hematology
[3] Jiangsu Tumor Hospital,Department of Pathology
来源：
BMC Gastroenterology | / 14卷
关键词：
Colorectal cancer; ERCC1; TS; Real-time PCR; Adjuvant chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Association between ERCC1 and TS mRNA levels and disease free survival in colorectal cancer patients receiving oxaliplatin and fluorouracil (5-FU) adjuvant chemotherapy
    Li, Sheng
    Zhu, Liangjun
    Yao, Li
    Xia, Lei
    Pan, Liangxi
    BMC GASTROENTEROLOGY, 2014, 14
  • [2] ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy
    Shirota, Y
    Stoehlmacher, J
    Brabender, J
    Xiang, YP
    Uetake, H
    Danenberg, KD
    Groshen, S
    Tsao-Wei, DD
    Danenberg, PV
    Lenz, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (23) : 4298 - 4304
  • [3] ERCC1 and the Prognosis for Patients With Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy
    Baek, Moo-Jun
    ANNALS OF COLOPROCTOLOGY, 2015, 31 (03) : 81 - 81
  • [4] ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy
    Metzger, R
    Leichman, CG
    Danenberg, KD
    Danenberg, PV
    Lenz, HJ
    Hayashi, K
    Groshen, S
    Salonga, D
    Cohen, H
    Laine, L
    Crookes, P
    Silberman, H
    Baranda, J
    Konda, K
    Leichman, L
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) : 309 - 316
  • [5] Prognostic Value of ERCC1, Thymidylate Synthase, and Glutathione S-Transferase π for 5-FU/Oxaliplatin Chemotherapy in Advanced Colorectal Cancer
    Kim, Sung-Hyun
    Kwon, Hyuk-Chan
    Oh, Sung Yong
    Lee, Dong Mee
    Lee, Suee
    Lee, Jong-Hoon
    Roh, Mee-Sook
    Kim, Dae-Cheol
    Park, Ki-Jae
    Choi, Hong-Jo
    Kim, Hyo-Jin
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (01): : 38 - 43
  • [6] Prognostic value of ERCC1, thymidylate synthase and glutathione S-transferase π for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
    Kwon, H.
    Roh, M. S.
    Oh, S. Y.
    Kim, S.
    Lee, J. H.
    Kim, J.
    Park, J. I.
    Park, K. J.
    Choi, H. J.
    Kim, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 172S - 172S
  • [7] Adjuvant chemotherapy of patients with primary breast cancer (PABC) by fluorouracil (5-FU)
    Hazova, TV
    Koritova, LI
    Ilyin, NV
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S32 - S32
  • [8] Association between polymorphisms of ERCC1 and survival in epithelial ovarian cancer patients with chemotherapy
    Li Yan
    Yang Shu-Ying
    Kang Shan
    Yip, Benjamin H. K.
    Zhou Rong-Miao
    Wang Na
    Sun Hai-Yan
    PHARMACOGENOMICS, 2012, 13 (04) : 419 - 427
  • [9] Methotrexate (MTX) and 5-fluorouracil (5-FU) in advanced colorectal cancer patients previously treated with adjuvant 5-FU
    Pronzato, P
    Vaira, F
    Viganni, A
    Losardo, P
    Bertelli, G
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 760 - 760
  • [10] Intratumoral induction of thymidylate synthase mRNA by 5-FU in colorectal cancer patients:: association with survival
    Tanaka-Nozaki, M
    Tajiri, T
    Tanaka, N
    Furukawa, K
    Takasaki, H
    Yoshimura, K
    Suzuki, H
    Naito, Z
    Sugizaki, Y
    Merk, HF
    Blömeke, B
    Kato, S
    ONCOLOGY REPORTS, 2003, 10 (05) : 1425 - 1429
12345